Why interferon beta 1b was licensed is a mystery
- 3 August 1996
- Vol. 313 (7052) , 297-298
- https://doi.org/10.1136/bmj.313.7052.297c
Abstract
EDITOR,—Patients with multiple sclerosis are interested in whether they can still go to work, get out of bed to go to the lavatory, or stand on one leg to put the other one through their pants—that is to say, they are interested in disability. Interferon beta …Keywords
This publication has 2 references indexed in Scilit:
- Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.1995
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 1993